“Twinkle After-Effect" Can Help Retinal Patients Detect Vision Loss Quickly And Cheaply
November 2, 2007
Adapted from the Schepens Eye Research Institute
Scientists at
Schepens Eye Research Institute, an affiliate of Harvard Medical School—have
discovered a simple and inexpensive way for patients with retinal and other eye
disease to keep track of changes in their vision loss. In a study published in
the October 24, 2007 edition of the Public Library of Science ONE they
demonstrate that a compelling visual illusion known as the induced twinkle
after-effect (TAE) can accurately identify the location and breadth of actual
blind spots in people with retinal disease. The twinkle after-effect is a
“twinkling” that people can see in a blind spot when they stare at a blank
screen after staring at a noisy visual target such as a detuned television
screen.
“Our hope is that we can make this simple technique available
online or on a DVD,” says Dr. Peter Bex, associate scientist at Schepens Eye
Research Institute and the principal investigator of the study. “This will be
particularly helpful with patients who have glaucoma, diabetic retinopathy or
macular degeneration where early detection of changes in vision can impact the
effectiveness of treatments.”
According to Bex, many people fail to seek
help when they develop blind spots in their vision, because their brains
automatically compensate or “fill in” the missing information in their visual
field. Since everyone has a blind spot where the optic nerve meets the retina,
this perceptual “fill in” process is useful for normally sighted people,
allowing them a complete visual image. “But this innate process can mask the
effects of serious disorders such as diabetic retinopathy and glaucoma and keep
sufferers from seeking help until the vision loss is very serious or they bump
into objects they can no longer see.”
In 1992 scientists became aware of
what they eventually named the “twinkle after effect.” They discovered that when
someone looks at a television screen filled with static noise while covering
part of their visual field with a small patch, the formerly patched area is left
with a twinkling sensation after the noise is turned off and the person looks at
a blank screen. The rest of the visual field does not experience the twinkling
effect, which was described by one patient as resembling a moving cumulous
cloud. “While this discovery was intriguing, it wasn't clear how it could be
used for patients,” says Bex.
In the past several years, Bex and his
team began to understand its potential. “We theorized that if people with blind
spots stared at a noisy screen, the blind areas would “twinkle” when the screen
was turned off and their eyes focused on a blank screen. These ‘twinkling' blind
spot areas could then easily be mapped,” he says.
To test their theory,
Bex and his team asked eight patients with macular degeneration to undergo a
conventional retinal test and his “twinkling after-effect” test. The team
provided a blank touch screen—after the noisy screen—so patients could outline
the twinkling areas with their finger.
The team found that the results
of the two tests matched in 75 percent of cases, and visual defects could be
detected in areas that are not accessible to conventional tests, confirming his
belief that TAE could be used diagnostically. “This tool cannot replace the more
sophisticated technique but we believe it is a powerful, simple tool that
patients can use daily in the privacy of their home to detect any changes in
their vision,” he says. “If a patient detects a change, his or her physician can
then study it more closely and offer therapy.”
While the results of this
small study are very encouraging, Bex says the next step is to do a larger
clinical study.
Ultimately Bex sees this type of test being free to the
public on the Internet or distributed through a public health entity. “We really
believe this could have a great impact on the visual health of the community,”
says Bex.
View all news updates for glaucoma
Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.